HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Previous close
$4.02
Day range
$4.00 - $4.10
Year range
$4.00 - $11.90
Market cap
37.18M USD
Avg Volume
4.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 305.01K | -85.88% |
Operating expense | 30.78M | -19.99% |
Net income | -22.86M | -190.26% |
Net profit margin | -7.49K | -1,956.35% |
Earnings per share | -6.39 | -253.44% |
EBITDA | -17.95M | -157.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 56.57M | 275.93% |
Total assets | 83.94M | 64.90% |
Total liabilities | 26.64M | 34.24% |
Total equity | 57.30M | — |
Shares outstanding | 9.23M | — |
Price to book | 0.65 | — |
Return on assets | -84.05% | — |
Return on capital | -113.54% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -22.86M | -190.26% |
Cash from operations | -13.45M | -764.73% |
Cash from investing | -67.86K | 42.37% |
Cash from financing | 67.64M | 706.40% |
Net change in cash | 54.14M | 706.30% |
Free cash flow | -11.12M | -1,074.67% |
About
Founded
2014
Headquarters
Website
Employees
57